Cylerus, Inc.

Beaverton, OR · Medtech · Defunct

Implantable sirolimus-eluting cuff and reservoir system for vascular grafts that delivers anti-proliferative drug locally to prevent graft failure

Claim this profile

Follows are private to you and power your alerts

Updated · cylerus.com

Sector
Medtech
Headquarters
Beaverton, OR
Total capital
$1.7M
Federal grants
$1.7M
2 awards · 2017–2018
Rank in peer group#134 of 477
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
None on recordNo federal contract awards found.
Granted patents
0
7 pending

Capital timeline

20172018FEDERAL ↑EQUITY ↓Cumulative $1.7M$604K$1.1M
20172018FEDERAL ↑EQUITY ↓Cumulative $1.7M$604K$1.1M

Latest events

  • Federal grantHealth and Human S · Phase II · Localized Delivery of Sirolimus to Hemodialysis Vascular Access Grafts$1.1M
  • Federal grantHealth and Human S · Phase II · Localized Delivery of Sirolimus to Hemodialysis Vascular Access Grafts$604K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 477 peers

Line = median

Medtech · Device

  • Federal grants#134 · top 28%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 0 granted of 7
  • PendingCompression-Activated Refillable Pump for Controlled Drug DeliveryUSPTOApplication 16905176
  • PendingDual-Lumen Drug Reservoir Fill and Withdrawal Devices and MethodsUSPTOApplication 16373977
  • PendingInfusable Solution For Local Treatment Of Blood Vessels And Vascular Grafts And Methods Of Using Such A SolutionUSPTOApplication 15447073
Show all 7 patent records
  • Compression-Activated Refillable Pump for Controlled Drug DeliveryDec 24, 2020 · Application 16905176Pending
  • Dual-Lumen Drug Reservoir Fill and Withdrawal Devices and MethodsOct 10, 2019 · Application 16373977Pending
  • Infusable Solution For Local Treatment Of Blood Vessels And Vascular Grafts And Methods Of Using Such A SolutionSep 7, 2017 · Application 15447073Pending
  • Extended-Release Drug Delivery Devices and MethodsApplication 62652430Pending
  • Dual-lumen Drug Reservoir Fill And Withdrawal Devices And MethodsApplication PCTUS2019025531Pending
  • Compression-activated Refillable Pump For Controlled Drug DeliveryApplication PCTUS2020038409Pending
  • Compression-Activated Refillable Pump for Controlled Drug DeliveryApplication 62863553Pending
  • Lyra Therapeutics, Inc.Similar federal contract value in Medtech · null in contracts
  • INOVASC, LLCSimilar federal contract value in Medtech · null in contracts
  • MONOD BIO, INC.Similar federal contract value in Medtech · null in contracts
  • COOLER HEADS CARE INCSimilar federal contract value in Medtech · null in contracts
  • Adient Medical Inc.Similar federal contract value in Medtech · null in contracts
  • Paratus DiagnosticsSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .